Squarepoint Ops LLC Raises Stake in Arteris, Inc. $AIP

Squarepoint Ops LLC increased its stake in Arteris, Inc. (NASDAQ:AIPFree Report) by 143.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 120,957 shares of the company’s stock after purchasing an additional 71,340 shares during the quarter. Squarepoint Ops LLC owned 0.28% of Arteris worth $1,153,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in AIP. Raymond James Financial Inc. acquired a new stake in shares of Arteris during the 2nd quarter valued at approximately $32,000. Savant Capital LLC purchased a new position in Arteris in the 2nd quarter valued at approximately $97,000. Kapitalo Investimentos Ltda acquired a new position in Arteris during the second quarter worth $104,000. Strs Ohio purchased a new stake in Arteris during the first quarter worth $104,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Arteris during the second quarter worth $151,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris Price Performance

Shares of NASDAQ AIP opened at $15.74 on Friday. The company has a 50-day simple moving average of $14.63 and a 200-day simple moving average of $11.34. The company has a market cap of $687.52 million, a PE ratio of -18.96 and a beta of 1.49. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $19.85.

Arteris (NASDAQ:AIPGet Free Report) last announced its earnings results on Tuesday, November 4th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. Arteris had a negative net margin of 52.25% and a negative return on equity of 8,546.17%. The firm had revenue of $17.41 million for the quarter, compared to analyst estimates of $17.00 million. On average, analysts anticipate that Arteris, Inc. will post -0.73 EPS for the current year.

Insiders Place Their Bets

In other Arteris news, CEO K Charles Janac sold 70,000 shares of the stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $17.71, for a total transaction of $1,239,700.00. Following the transaction, the chief executive officer owned 9,469,071 shares of the company’s stock, valued at $167,697,247.41. This trade represents a 0.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Paul L. Alpern sold 7,500 shares of the business’s stock in a transaction on Thursday, December 4th. The shares were sold at an average price of $16.09, for a total transaction of $120,675.00. Following the sale, the vice president directly owned 65,277 shares of the company’s stock, valued at $1,050,306.93. This represents a 10.31% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 820,825 shares of company stock valued at $12,276,775 in the last quarter. Corporate insiders own 29.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on AIP. TD Cowen lifted their price target on Arteris from $15.00 to $16.50 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Jefferies Financial Group upgraded shares of Arteris to a “hold” rating in a report on Tuesday, October 28th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a report on Wednesday, October 8th. Cowen reissued a “buy” rating on shares of Arteris in a research note on Wednesday, November 5th. Finally, Rosenblatt Securities reaffirmed a “buy” rating and issued a $20.00 target price on shares of Arteris in a research note on Monday, December 15th. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $17.50.

View Our Latest Research Report on AIP

Arteris Profile

(Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Further Reading

Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIPFree Report).

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.